Strober BE - Search Results

1

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Ghosh S, Gensler LS, Yang Z, Gasink C, Chakravarty SD, Farahi K, Ramachandran P, Ott E, Strober BE. Ghosh S, et al. Among authors: strober be. Drug Saf. 2019 Jun;42(6):751-768. doi: 10.1007/s40264-019-00797-3. Drug Saf. 2019. PMID: 30739254 Free PMC article. Clinical Trial.

2

Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.

Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE; National Psoriasis Foundation. Menon K, et al. Among authors: strober be. J Am Acad Dermatol. 2010 Feb;62(2):291-9. doi: 10.1016/j.jaad.2009.03.047. Epub 2009 Jul 31. J Am Acad Dermatol. 2010. PMID: 19646777 Review.

3

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.

Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, Guzzo C, Xia Y, Zhou B, Li S, Dooley LT, Goldstein NH, Menter A; ACCEPT Study Group. Griffiths CE, et al. Among authors: strober be. N Engl J Med. 2010 Jan 14;362(2):118-28. doi: 10.1056/NEJMoa0810652. N Engl J Med. 2010. PMID: 20071701 Free article. Clinical Trial.

4

Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial.

Strober BE, Sobell JM, Duffin KC, Bao Y, Guérin A, Yang H, Goldblum O, Okun MM, Mulani PM. Strober BE, et al. Br J Dermatol. 2012 Dec;167(6):1374-81. doi: 10.1111/bjd.12000. Epub 2012 Nov 2. Br J Dermatol. 2012. PMID: 22897348 Clinical Trial.

5

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.

Papp KA, Menter A, Strober B, Langley RG, Buonanno M, Wolk R, Gupta P, Krishnaswami S, Tan H, Harness JA. Papp KA, et al. Br J Dermatol. 2012 Sep;167(3):668-77. doi: 10.1111/j.1365-2133.2012.11168.x. Br J Dermatol. 2012. PMID: 22924949 Clinical Trial.

6

PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

Papp KA, Strober B, Augustin M, Calabro S, Londhe A, Chevrier M; PSOLAR investigators and Steering Committee. Papp KA, et al. J Drugs Dermatol. 2012 Oct;11(10):1210-7. J Drugs Dermatol. 2012. PMID: 23134986

7

Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.

Langley RG, Papp K, Gottlieb AB, Krueger GG, Gordon KB, Williams D, Valdes J, Setze C, Strober B. Langley RG, et al. J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1252-61. doi: 10.1111/j.1468-3083.2012.04705.x. Epub 2012 Nov 16. J Eur Acad Dermatol Venereol. 2013. PMID: 23157612

8

Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases.

de Souza A, Ali-Shaw T, Reddy SM, Fiorentino D, Strober BE. de Souza A, et al. Among authors: strober be. Br J Dermatol. 2013 Jan;168(1):210-2. doi: 10.1111/j.1365-2133.2012.11206.x. Br J Dermatol. 2013. PMID: 23278559

9

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.

Papp KA, Griffiths CE, Gordon K, Lebwohl M, Szapary PO, Wasfi Y, Chan D, Hsu MC, Ho V, Ghislain PD, Strober B, Reich K; PHOENIX 1 Investigators; PHOENIX 2 Investigators; ACCEPT Investigators. Papp KA, et al. Br J Dermatol. 2013 Apr;168(4):844-54. doi: 10.1111/bjd.12214. Br J Dermatol. 2013. PMID: 23301632

10

Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy.

Strober BE, Poulin Y, Teller C, Wang Y, Williams DA, Goldblum OM. Strober BE, et al. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1701-6. doi: 10.1111/jdv.12372. Epub 2014 Jan 15. J Eur Acad Dermatol Venereol. 2014. PMID: 24422992 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters